2024 annual financial data

Cullinan Therapeutics 2024 Net margin

Cullinan Therapeutics 2024 net margin with verified reported values.

Direct answer

Net margin was Not calculable.

Operating income was -196,919,000 USD and net income was -167,383,000 USD.
Operating cash flow was -145,303,000 USD.

Get free Cullinan Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-196,919,000 USD
Net income
-167,383,000 USD
Operating cash flow
-145,303,000 USD